Pharmacogenetic study of ABCB1 and CYP3A5 genes during the first year following heart transplantation regarding tacrolimus or cyclosporine levels

Transplantation Proceedings

Volumn 43, Issue 6, 2011, Pages 2241-2243

  Jordan De Luna C ^a   Herrero Cervera, M J ^b   Sanchez Lazaro I ^a   Almenar Bonet, L ^a   Poveda Andres J L ^a   Alino Pellicer S F ^a,c  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYTOCHROME P450 3A5; MULTIDRUG RESISTANCE PROTEIN 1; TACROLIMUS;

ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FOLLOW UP; GENE EXPRESSION; GENOTYPE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CYCLOSPORINE; CYTOCHROME P-450 CYP3A; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; GENE FREQUENCY; GENOTYPE; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LINKAGE DISEQUILIBRIUM; P-GLYCOPROTEIN; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SPAIN; TACROLIMUS;

EID: 80051689011     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.05.008     Document Type: Article

References (5)

1. J. Shin, S.R. Kayser, and T.Y. Langaee Pharmacogenetics: from discovery to patients care Am J Health Syst Pharm 66 2009 625
2. R. Weinshilboum, and L. Wang Pharmacogenomics: bench to bedside Nat Rev Drug Discov 3 2004 739
3. A. Provenzani, M. Notarbartolo, and M. Labbozzetta The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients Ann Transplant 14 2009 23
4. W. Zhao, V. Elie, and G. Roussey Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients Clin Pharmacol Ther 86 2009 609
5. M.J. Herrero, L. Almenar, and C. Jordán Clinical interest of pharmacogenetic polymorphisms in the immunosuppressive treatment after heart transplantation Transplant Proc 42 2010 3181